Five years ago, many critics questioned the value of lipid-lowering therapy. Today, the clinical benefits of statins are well
documented, but the challenge remains to fully implement these benefits across the wide spectrum of the at-risk population,
and continue to advance our understanding regarding the potential for the benefits of statins across an even broader range
of select patient populations.